Mobilome and genetic modification of bifidobacteria

Beneficial Microbes

Volumn 4, Issue 2, 2013, Pages 143-166

  Guglielmetti, S ^a   Mayo, B ^b   Alvarez Martin P ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^c NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Bifidobacteria; Bifidobacterium; Genetic engineering.; Plasmid; Vector

Indexed keywords

BACTERIAL VECTOR;

ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM CONJUGATION; BIFIDO BACTERIUM RUMINALE; BIFIDOBACTERIACEAE; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM ASTEROIDES; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM CATENULATUM; BIFIDOBACTERIUM DENTIUM; BIFIDOBACTERIUM GLUTAMICUM; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM INFANTIS; BIFIDOBACTERIUM MAGNUM; BIFIDOBACTERIUM PSEUDOCATENULATUM; BIFIDOBACTERIUM PSEUDOLONGUM; BIFIDOBACTERIUM THERMOPHILUS; DNA MODIFICATION; DRUG DELIVERY SYSTEM; ELECTROPORATION; ELECTROTRANSFORMATION; GENE EXPRESSION REGULATION; GENE INSERTION SEQUENCE; MOLECULAR MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PROCESS OPTIMIZATION; REPORTER GENE; SEQUENCE ANALYSIS; TRANSPOSON;

EID: 84875246839     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2012.0031     Document Type: Article

References (145)

1. Álvarez-Martín, P., Fernández, M., O'Connell-Motherway, M., O'Connell, K.J., Sauvageot, N., Fitzgerald, G.F., Macsharry, J., Zomer, A. and Van Sinderen, D., 2012b. A conserved two-component signal transduction system controls the response to phosphate starvation in Bifidobacterium breve UCC2003. Applied and Environmental Microbiology 78: 5258-5269.
2. Álvarez-Martín, P., Flórez, A.B. and Mayo, B., 2007b. Screening for plasmids among human bifidobacteria species: Sequencing and analysis of pBC1 from Bifidobacterium catenulatum L48. Plasmid 57: 165-174.
3. Álvarez-Martín, P., Flórez, A.B., Margolles, A., Del Solar, G. and Mayo, B., 2008. Improved cloning vectors for bifidobacteria, based on the Bifidobacterium catenulatum pBC1 replicon. Applied and Environmental Microbiology 74: 4656-4665.
4. Álvarez-Martín, P., O'Connell Motherway, M., Turroni, F., Foroni, E., Ventura, M. and Van Sinderen, D., 2012a. A two-component regulatory system controls autoregulated serpin expression in Bifidobacterium breve UCC2003. Applied and Environmental Microbiology 78: 7032-7041.
5. Álvarez-Martín, P., O'Connell-Motherway, M., Van Sinderen, D. and Mayo, B., 2007a. Functional analysis of the pBC1 replicon from Bifidobacterium catenulatum L48. Applied Microbiology and Biotechnology 76: 1395-1402.
6. Ammor, M.S., Flórez, A.B., Álvarez-Martín, P., Margolles, A. and Mayo, B., 2008. Analysis of tetracycline resistance tet(W) genes and their flanking sequences in intestinal Bifidobacterium species. Journal of Antimicrobials and Chemotherapy 62: 688-693.
7. Argnani, A., Leer, R.J., Van Luijk, N. and Pouwels, P.H., 1996. A convenient and reproducible method to genetically transform bacteria of the genus Bifidobacterium. Microbiology 142: 109-114.
8. Arigoni, F. and Delley, M., 2008. Genetic remodelling in Bifidobacterium. International Patent WO 2008/019886 A1.
9. Barrangou, R., Briczinski, E.P., Traeger, L.L., Loquasto, J.R., Richards, M., Horvath, P., Coûté-Monvoisin, A.C., Leyer, G., Rendulic, S., Steele, J.L., Broadbent, J.R., Oberg, T., Dudley, E.G., Schuster, S,. Romero, D.A. and Roberts, R.F., 2009. Comparison of the complete genome sequences of Bifidobacterium animalis subsp. lactis DSM 10140 and Bl-04. Journal of Bacteriology 191: 4144-4151.
10. Briggs, M., 1953. An improved medium for lactobacilli. Journal of Dairy Research 20: 36-40.
11. Brown, D.P., Idler, K.B. and Katz, L., 1990. Characterization of the genetic elements required for site-specific integration of plasmid pSE211 in Saccharopolyspora erythraea. Journal of Bacteriology 172: 1877-1888.
12. Campbell, A.M., 1992. Chromosomal insertion sites for phages and plasmids. Journal of Bacteriology 174: 7495-7499.
13. Canchaya, C., Proux, C., Fournous, G., Bruttin, A. and Brussow, H., 2003. Prophage genomics. Microbiology and Molecular Biology Reviews 67: 238-276.
14. Claesson, M.J., Cusack, S., O'Sullivan, O., Greene-Diniz, R., De Weerd, H., Flannery, E., Marchesi, J.R., Falush, D., Dinan, T., Fitzgerald, G., Stanton, C., Van Sinderen, D., O'Connor Moderway, M., Harnedy, N., O'Connor, K., Henry, C., O'Mahony, D., Fitzgerald, A.P., Shanahan, F., Twomey, C., Hill, C., Ross, R.P. and O'Toole, P.W., 2011. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proceedings of the National Academy of Sciences of the USA 108: 4586-4591.
15. Combes, P., Till, R., Bee, S. and Smith, M.C.M., 2002. The Streptomyces genome contains multiple pseudo-attB sites for the phage C31- encoded site-specific recombination system. Journal of Bacteriology 184: 5746-5752.
16. Corneau, N., Emond, E. and LaPointe, G., 2004. Molecular characterization of three plasmids from Bifidobacterium longum. Plasmid 51: 87-100.
17. Cronin, M., Knobel, M., O'Connell-Motherway, M., Fitzgerald, G.F. and Van Sinderen, D., 2007. Molecular dissection of a bifidobacterial replicon. Applied and Environmental Microbiology 73: 7858-7866.
18. Cronin, M., Morrissey, D., Rajendran, S., El Mashad, S.M., Van Sinderen, D., O'Sullivan, G.C. and Tangney, M., 2010. Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors. Molecular Therapy 18: 1397-1407.
19. Cronin, M., Sleator, R.D., Hill, C., Fitzgerald, G.F. and Van Sinderen, D., 2008. Development of a luciferase-based reporter system to monitor Bifidobacterium breve UCC2003 persistence in mice. BMC Microbiology 8: 161.
20. Del Solar, G., Giraldo, R., Ruiz-Echevarría, M.J., Espinosa, M. and Díaz-Orejas, R., 1998. Replication and control of circular bacterial plasmids. Microbiology and Molecular Biology Reviews 62: 434-464.
21. Deng, Q., Zeng, W. and Yu, Z., 2009. Signal peptide of arabinosidase enhances secretion of interferon-alpha2b protein by Bifidobacterium longum. Archives of Microbiology 191: 681-686.
22. European Commission (EC), 2007. Regulation (EC) 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. Official Journal of the European Union L12: 3-18.
23. Fanaro, S., Chierici, R., Guerrini, P. and Vigi, V., 2003. Intestinal microflora in early infancy: composition and development. Acta Paediatrica 91: 48-55.
24. Fanning, S., Hall, L. and Van Sinderen, D., 2012a. Bifidobacterium breve UCC2003 surface exopolysaccharide production is a beneficial trait mediating commensal-host interaction through immune modulation and pathogen protection. Gut Microbes 3, in press. DOI: http://dx.doi.org/10.4161/gmic.20630.
25. Fanning, S., Hall, L.J., Cronin, M., Zomer, A., MacSharry, J., Goulding, D., O'Connell Motherway, M., Shanahan, F., Nally, K., Dougan, G. and Van Sinderen, D., 2012b. Bifidobacterial surfaceexopolysaccharide facilitates commensal-host interaction through ,immune modulation and pathogen protection. Proceedings of the National Academy of Sciences of the USA 109: 2108-2113.
26. Fischer, W., 1987. Analysis of the lipoteichoic acid-like macroamphiphile from Bifidobacteriuim bifidum subspecies pennsylvanium by oneand two-dimensional 1H- and 13C-NMR spectroscopy. European Journal of Biochemistry 165: 647-652.
27. Foroni, E., Serafini, F., Amidani, D., Turroni, F., He, F., Bottacini, F., O'Connell Motherway, M., Viappiani, A., Zhang, Z., Rivetti, C., Van Sinderen, D. and Ventura, M., 2011. Genetic analysis and morphological identification of pilus-like structures in members of the genus Bifidobacterium. Microbial Cell Factory 10: S16.
28. Frost, L.S., Leplae, R., Summers, A.O. and Toussaint, A. 2005. Mobile genetic elements: the agents of open source evolution. Nature Reviews in Microbiology 3: 722-732.
29. Fu, G.F., Li, X., Hou, Y.Y., Fan, Y.R., Liu, W.H. and Xu, G.X., 2005. Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer. Cancer Gene Therapy 12: 133-140.
30. Fujimori, M., 2006. Genetically engineered Bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients. Breast Cancer 13: 27-31.
31. Fukiya, S., Sugiyama, T., Kano, Y. and Yokota, A., 2010. Characterization of an insertion sequence-like element, ISBlo15, identified in a sizeincreased cryptic plasmid pBK283 in Bifidobacterium longum BK28. Journal of Bioscience and Bioengineering 110: 141-146.
32. Garrigues, C., Johansen, E. and Pedersen, M.B., 2010. Complete genome sequence of Bifidobacterium animalis subsp. lactis BB- 12, a widely consumed probiotic strain. Journal of Bacteriology 192: 2467-2468.
33. Gibbs, M.J., Smeianov, V.V., Steele, J.L., Upcroft, P. and Efimov, B.A., 2006. Two families of rep-like genes that probably originated by interspecies recombination are represented in viral, plasmid, bacterial, and parasitic protozoan genomes. Molecular Biology and Evolution 23: 1097-1100.
34. González Vara, A., Rossi, M., Altomare, L., Eikmanns, B. and Matteuzzi, D., 2003. Stability of recombinant plasmids on the continuous culture of Bifidobacterium animalis ATCC 27536. Biotechnology and Bioengineering 84: 145-150.
35. Guglielmetti, S., Ciranna, A., Mora, D., Parini, C. and Karp, M., 2008a. Construction, characterization and exemplificative application of bioluminescent Bifidobacterium longum biovar longum. International Journal of Food Microbiology 124: 285-290.
36. Guglielmetti, S., Karp, M., Mora, D., Tamagnini, I. and Parini, C., 2007b. Molecular characterization of Bifidobacterium longum biovar longum NAL8 plasmids and construction of a novel replicon screening system. Applied Microbiology and Biotechnology 74: 1053-1061.
37. Guglielmetti, S., Mora, D. and Parini, C., 2007a. Small rolling circle plasmids in Bacillus subtilis and related species: organization, distribution, and their possible role in host physiology. Plasmid 57: 245-264.
38. Guglielmetti, S., Mora, D., Gschwender, M. and Popp, K., 2011. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life ' a double-blind, placebo-controlled study. Alimentary Pharmacology and Therapy 33: 1123-1132.
39. Guglielmetti, S., Tamagnini, I., Mora, D., Minuzzo, M., Scarafoni, A., Arioli, S., Hellman, J., Karp, M. and Parini, C., 2008b. Implication of an outer surface lipoprotein in adhesion of Bifidobacterium bifidum to Caco-2 cells. Applied and Environmental Microbiology 74: 4695-4702.
40. Hamaji, Y., Fujimori, M., Sasaki, T., Matsuhashi, H., Matsui-Seki, K., Shimatani-Shibata, Y., Kano, Y., Amano, J. and Taniguchi, S., 2007. Strong enhancement of recombinant cytosine deaminase activity in Bifidobacterium longum for tumor-targeting enzyme/prodrug therapy. Bioscience, Biotechnology, and Biochemistry 71: 874-883.
41. Hartke, A., Benachour, A., Bouibonnes, P. and Auffray, Y., 1996. Characterisation of a complex restriction/modification system detected in a Bifidobacterium longum strain. Applied Microbiology and Biotechnology 45: 132-136.
42. Hayes, F., 2003. The function and organization of plasmids. Methods in Molecular Biology 235: 1-17.
43. Hendrix, R.W., Smith, M.C.M., Burns, R.N., Ford, M.E. and Hatfull, G.F., 1999. Evolutionary relationships among diverse bacteriophages and prophages: all the world's a phage. Proceedings of the National Academy of Sciences of the USA 96: 2192-2197.
44. Hidaka, A., Hamaji, Y., Sasaki, T., Taniguchi, S. and Fujimori, M., 2007. Exogenous cytosine deaminase gene expression in Bifidobacterium breve I-53-8w for tumor-targeting enzyme/prodrug therapy. Bioscience, Biotechnology, and Biochemistry 71: 2921-2926.
45. Hou, X. and Liu, J.E., 2006. Construction of Escherichia coli- Bifidobacterium longum shuttle vector and expression of tumor suppressor gene PTEN in B. longum. Wei Sheng Wu Xue Bao 46: 347-352.
46. Hu, B., Kou, L., Li, C., Zhu, L.P., Fan, Y.R., Wu, Z.W., Wang, J.J. and Xu, G.X., 2009. Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth. Cancer Gene Therapy 16: 655-663.
47. Ishikawa, H., Matsumoto, S., Ohashi, Y., Imaoka, A., Setoyama, H., Umesaki, Y., Tanaka, R. and Otani, T., 2011. Beneficial effects of probiotic Bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study. Digestion 84: 128-133.
48. Ivanov, D., Emonet, C., Foata, F., Affolter, M., Delley, M., Fisseha, M., Blum-Sperisen, S., Kochhar, S. and Arigoni, F., 2006. A serpin from the gut bacterium Bifidobacterium longum inhibits eukaryotic elastase-like serine proteases. Journal of Biological Chemistry 281: 17246-17252.
49. Iwata, M. and Morishita, T., 1989. The presence of plasmids in Bifidobacterium breve. Letters in Applied Microbiology 9: 165-168.
50. Ji, G.E., Park, M.S., Kang, Y.H. and Seo, J.M. 2005. Plasmid originated from Bifidobacterium, recombinant expression vector using the plasmid and transformation method. United States Patent 6887702.
51. Katan, M.B., 2012. Why the European Food Safey Authority was right to reject health claims for probiotics. Beneficial Microbes 3: 85-89.
52. Kazimierczak, K.A., Flint, H.J. and Scott, K.P., 2006. Comparative analysis of sequences flanking tet(W) resistance genes in multiple species of gut bacteria. Antimicrobial Agents and Chemotherapy 50: 2632-2639.
53. Khokhlova, E.V., Efimov, B.A., Kafarskaia, L.I. and Shkoporov, A.N., 2010. Heterologous expression of secreted biologically active human interleukin-10 in Bifidobacterium breve. Archives of Microbiology 192: 769-774.
54. Kim, J.F., Jeong, H., Yu, D.S., Choi, S.H., Hur, C.G., Park, M.S., Yoon, S.H., Kim, D.W., Ji, G.E., Park, H.S. and Oh, T.K., 2009. Genome sequence of the probiotic bacterium Bifidobacterium animalis subsp. lactis AD011. Journal of Bacteriology 191: 678-679.
55. Kim, J.Y., Wang, Y,. Park, M.S. and Ji, G.E., 2010. Improvement of transformation efficiency through in vitro methylation and SacII site mutation of plasmid vector in Bifidobacterium longum MG1. Journal of Microbiology and Biotechnology 20: 1022-1026.
56. Kimura, N.T., Taniguchi, S. and Aoki, K., 1980. Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration. Cancer Research 40: 2061-2068.
57. Klijn, A., Moine, D., Delley, M., Mercenier, A., Arigoni, F. and Pridmore, R.D., 2006. Construction of a reporter vector for the analysis of Bifidobacterium longum promoters. Applied and Environmental Microbiology 72: 7401-7405.
58. Kullen, M.J. and Klaenhammer, T.R., 2000. Genetic modification of intestinal lactobacilli and bifidobacteria. Current Issues in Molecular Biology 2: 41-50.
59. Leahy, S.C., Higgins, D.G., Fitzgerald, G.F. and Van Sinderen, D., 2005. Getting better with bifidobacteria. Journal of Applied Microbiology 98: 1303-1315.
60. LeDeaux, J.R. and Grossman, A.D., 1995. Isolation and characterization of kinC, a gene that encodes a sensor kinase homologous to the sporulation sensor kinases KinA and KinB in Bacillus subtilis. Journal of Bacteriology 177: 166-175.
61. Lee, J.H. and O'Sullivan, D.J., 2006. Sequence analysis of two cryptic plasmids from Bifidobacterium longum DJO10A and construction of a shuttle cloning vector. Applied and Environmental Microbiology 72: 527-535.
62. Lee, J.H., Karamychev, V.N., Kozyavkin, S.A., Mills, D., Pavlov, A.R., Pavlova, N.V., Polouchine, N.N., Richardson, P.M., Shakhova, V.V., Slesarev, A.I., Weimer, B. and O'Sullivan, D.J., 2008. Comparative genomic analysis of the gut bacterium Bifidobacterium longum reveals loci susceptible to deletion during pure culture growth. BMC Genomics 9: 247.
63. Li, X., Fu, G.F., Fan, Y.R., Liu, W.H., Liu, X.J., Wang, J.J. and Xu, G.X., 2003. Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth. Cancer Gene Therapy 10: 105-111.
64. Long, R.T., Zeng, W.S., Chen, L.Y., Guo, J., Lin, Y.Z., Huang, Q.S. and Luo, S.Q., 2010. Bifidobacterium as an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice. International Journal of Obesity 34: 712-719.
65. MacConaill, L.E., Fitzgerald, G.F. and Van Sinderen, D., 2003. Investigation of protein export in Bifidobacterium breve UCC2003. Applied and Environmental Microbiology 69: 6994-7001.
66. Malmgren, R.A. and Flanigan, C.C., 1955. Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration. Cancer Research 15: 473-478.
67. Martín, M.C., Alonso, J.C., Suárez, J.E. and Álvarez, M.A., 2000. Generation of food-grade recombinant lactic acid bacterium strains by site-specific recombination. Applied and Environmental Microbiology 66: 2599-2604.
68. Masco, L., Huys, G., De Brandt, E., Temmerman, R. and Swings, J., 2005. Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteria. International Journal of Food Microbiology 102: 221-230.
69. Matsumura, H., Takeuchi, A. and Kano, Y., 1997. Construction of Escherichia coli-Bifidobacterium longum shuttle vector transforming B. longum 105-A and 108-A. Bioscience, Biotechnology, and Biochemistry 61: 1211-1212.
70. Matteuzzi, D. and Sozzi, T., 1970. Bifidobacterium bacteriophage from calf rumen. Zeitschrift für Allgemeine Mikrobiologie 11: 57-58.
71. Missich, R., Sgorbati, B. and Leblanc, D.J., 1994. Transformation of Bifidobacterium longum with pRM2, a constructed Escherichia coli-B. longum shuttle vector. Plasmid 32: 208-211.
72. Moon, G.S., Pyun, Y.R., Park, M.S., Ji, G.E. and Kim, W.J., 2005. Secretion of recombinant pediocin PA-1 by Bifidobacterium longum, using the signal sequence for bifidobacterial alpha-amylase. Applied and Environmental Microbiology 71: 5630-5632.
73. Moon, G.S., Wegmann, U., Gunning, A.P., Gasson, M.J. and Narbad, A., 2009. Isolation and characterization of a theta-type cryptic plasmid from Bifidobacterium longum FI10564. Journal of Microbiology and Biotechnology 19: 403-408.
74. Mueller, S., Saunier, K., Hanisch, C., Norin, E., Alm, L., Midtvedt, T., Cresci, A., Silvi, S., Orpianesi, C., Verdenelli, M.C., Clavel, T., Koebnick, C., Zunft, H.J., Doré, J. and Blaut, M., 2006. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Applied and Environmental Microbiology 72: 1027-1033.
75. Nakamura, T., Sasaki, T., Fujimori, M., Yazawa, K., Kano, Y., Amano, J. and Taniguchi, S., 2002. Cloned cytosine deaminase gene expression of Bifidobacterium longum and application to enzyme/pro-drug therapy of hypoxic solid tumors. Bioscience, Biotechnology, and Biochemistry 66: 2362-2366.
76. O'Connell Motherway, M., Fitzgerald, G.F. and Van Sinderen, D., 2011b. Metabolism of a plant derived galactose-containing polysaccharide by Bifidobacterium breve UCC2003. Microbial Biotechnology 4: 403-410.
77. O'Connell Motherway, M., Fitzgerald, G.F., Neirynck, S., Ryan, S., Steidler, L. and Van Sinderen, D., 2008. Characterization of ApuB, an extracellular type II amylopullulanase from Bifidobacterium breve UCC2003. Applied and Environmental Microbiology 74: 6271-6279.
78. O'Connell Motherway, M., O'Driscoll, J., Fitzgerald, G.F. and Van Sinderen, D., 2009. Overcoming the restriction barrier to plasmid transformation and targeted mutagenesis in Bifidobacterium breve UCC2003. Microbial Biotechnology 2: 321-332.
79. O'Connell Motherway, M., Zomer, A., Leahy, S.C., Reunanen, J., Bottacini, F., Claesson, M.J., O'Brien, F., Flynn, K., Casey, P.G., Muñoz, J.A., Kearney, B., Houston, A.M., O'Mahony, C., Higgins, D.G., Shanahan, F., Palva, A., De Vos, W.M., Fitzgerald. G.F., Ventura, M., O'Toole, P.W. and Van Sinderen, D., 2011a. Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor. Proceedings of the National Academy of Sciences of the USA 108: 11217-11222.
80. O'Riordan, K. and Fitzgerald, G.F., 1999. Molecular characterisation of a 5.75-kb cryptic plasmid from Bifidobacterium breve NCFB 2258 and determination of mode of replication. FEMS Microbiology Letters 174: 285-294.
81. Park, K.B., Ji, G.E., Park, M.S. and Oh, S.H., 2005a. Expression of rice glutamate decarboxylase in Bifidobacterium longum enhances gamma-aminobutyric acid production. Biotechnology Letters 27: 1681-1684.
82. Park, M.S., Kwon, B., Shim, J.J., Huh, C.S. and Ji, G.E., 2007. Heterologous expression of cholesterol oxidase in Bifidobacterium longum under the control of 16S rRNA gene promoter of bifidobacteria. Biotechnology Letters 30: 165-172.
83. Park, M.S., Lee, K.H. and Ji, G.E., 1997. Isolation and characterization of two plasmids from Bifidobacterium longum. Letters in Applied Microbiology 25: 5-7.
84. Park, M.S., Moon, H.W. and Ji, G.E., 2003. Molecular characterization of plasmid from Bifidobacterium longum. Journal of Microbiology and Biotechnology 13: 457-462.
85. Park, M.S., Seo, J.M., Kim, J.Y. and Ji, G.E., 2005b. Heterologous gene expression and secretion in Bifidobacterium longum. Lait 85: 1-8.
86. Park, M.S., Shin, D.W., Lee, K.H. and Ji, G.E., 1999. Sequence analysis of plasmid pKJ50 from Bifidobacterium longum. Microbiology 145: 585-592.
87. Park, Y.S., Kim, K.H., Park, J.H., Oh, I.K. and Yoon, S.S., 2008. Isolation and molecular characterization of a cryptic plasmid from Bifidobacterium longum. Biotechnology Letters 30: 145-151.
88. Parvez, S., Malik, K.A., Ah Kang, S. and Kim, H.Y., 2006. Probiotics and their fermented food products are beneficial for health. Journal of Applied Microbiology 100: 1171-1185.
89. Philippe, H. and Douady, C.J., 2003 Horizontal gene transfer and phylogenetics. Current Opinion in Microbiology 6: 498-505.
90. Pokusaeva, K., Neves, A.R., Zomer, A., O'Connell-Motherway, M., Macsharry, J., Curley, P., Fitzgerald, G.F. and Van Sinderen, D., 2010. Ribose utilization by the human commensal Bifidobacterium breve UCC2003. Microbial Biotechnology 3: 311-323.
91. Pokusaeva, K., O'Connell-Motherway, M., Zomer, A., Macsharry, J., Fitzgerald, G.F. and Van Sinderen, D., 2011. Cellodextrin utilization by Bifidobacterium breve UCC2003. Applied and Environmental Microbiology 77: 1681-1690.
92. Poquet, I., Ehrlich, S.D. and Gruss, A., 1998. An export-specific reporter designed for Gram-positive bacteria: application to Lactococcus lactis. Journal of Bacteriology 180: 1904-1912.
93. Reyes Escogido, M.L., De León Rodríguez, A. and Barba de la Rosa, A.P., 2007. A novel binary expression vector for production of human IL-10 in Escherichia coli and Bifidobacterium longum. Biotechnology Letters 29: 1249-1253.
94. Rhim, S.L., Park, M.S. and Ji, G.E., 2006. Expression and secretion of Bifidobacterium adolescentis amylase by Bifidobacterium longum. Biotechnology Letters 23: 163-168.
95. Roberts, A.P., Chandler, M., Courvalin, P., Guédon, G., Mullany, P., Pembroke, T., Rood, J.I., Smith, C.J., Summers, A.O., Tsuda, M. and Berg, D.E., 2008. Revised nomenclature for transposable genetic elements. Plasmid 60: 167-173.
96. Roberts, R.J. 1980. Restriction and modification enzymes and their recognition sequences. Nucleic Acids Research 8: r63-r80.
97. Rossi, M., Brigidi, P. and Matteuzzi, D., 1997. An efficient transformation system for Bifidobacterium spp. Letters in Applied Microbiology 24: 33-36.
98. Rossi, M., Brigidi, P. and Matteuzzi, D., 1998. Improved cloning vectors for Bifidobacterium spp. Letters in Applied Microbiology 26: 101-104.
99. Rossi, M., Brigidi, P., Gonzalez Vara y Rodriguez, A. and Matteuzzi, D., 1996. Characterization of the plasmid pMB1 from Bifidobacterium longum and its use for shuttle vector construction. Research in Microbiology 147: 133-143.
100. Ruiz, L., Álvarez-Martín, P., Mayo, B., De los Reyes-Gavilán, C.G., Gueimonde, M. and Margolles, A., 2012a. Controlled gene expression in bifidobacteria by use of a bile-responsive element. Applied and Environmental Microbiology 78: 581-585.
101. Ruiz, L., Zomer, A., O'Connell-Motherway, M., Van Sinderen, D. and Margolles, A., 2012b. Discovering novel bile protection systems in Bifidobacterium breve UCC2003 through functional genomics. Applied and Environmental Microbiology 78: 1123-1131.
102. Sangrador-Vegas, A., Stanton, C., Van Sinderen, D., Fitzgerald, G.F. and Ross, R.P., 2007. Characterization of plasmid pASV479 from Bifidobacterium pseudolongum subsp. globosum and its use for expression vector construction. Plasmid 58: 140-147.
103. Sasaki, T., Fujimori, M., Hamaji, Y., Hama, Y., Ito, K., Amano, J. and Taniguchi, S., 2006. Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats. Cancer Science 97: 649-657.
104. Scardovi, V., 1986. Genus Bifidobacterium. Orla-Jensen 1924, 472AL. In: Sneath, P.H.A., Mair, N.S., Sharpe, M.E. and Holt, J.G. (eds.) Bergey's manual of systematic bacteriology. Vol. 2. Williams and Wilkins, Baltimore, MD, USA, pp. 1418-1434.
105. Schell, M.A., Karmirantzou, M., Snel, B., Vilanova, D., Berger, B., Pessi, G., Zwahlen, M.C., Desiere, F., Bork, P., Delley, M., Pridmore, R.D. and Arigoni, F., 2002. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proceeding of the National Academy of Sciences of the USA 99: 14422-14427.
106. Sela, D.A., Chapman, J., Adeuya, A., Kim, J.H., Chen, F., Whitehead, T.R., Lapidus, A., Rokhsar, D.S., Lebrilla, C.B., German, J.B., Price, N.P., Richardson, P.M. and Mills, D.A., 2008. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proceedings of the National Academy of Sciences of the USA 105: 18964-18969.
107. Serafini, F., Turroni, F., Guglielmetti, S., Gioiosa, L., Foroni, E., Sanghez, V., Bartolomucci, A., O'Connell Motherway, M., Palanza, P., Van Sinderen, D. and Ventura, M., 2012. An efficient and reproducible method for transformation of genetically recalcitrant bifidobacteria. FEMS Microbiology Letters 333: 146-152.
108. Sgorbati, B., Scardovi, V. and Leblanc, D.J., 1982. Plasmids in the genus Bifidobacterium. Journal of General Microbiology 128: 2121-2131.
109. Sgorbati, B., Smiley, M.B. and Sozzi, T., 1983. Plasmids and phages in Bifidobacterium longum. Microbiologica 6: 169-173.
110. Shkoporov, A.N., Efimov, B.A., Khokhlova, E.V., Kafarskaia, L.I. and Smeianov, V.V., 2008b. Production of human basic fibroblast growth factor (FGF-2) in Bifidobacterium breve using a series of novel expression/secretion vectors. Biotechnology Letters 30: 1983-1988.
111. Shkoporov, A.N., Efimov, B.A., Khokhlova, E.V., Steele, J.L., Kafarskaia, L.I. and Smeianov, V.V., 2008a. Characterization of plasmids from human infant Bifidobacterium strains: sequence analysis and construction of E. coli-Bifidobacterium shuttle vectors. Plasmid 60: 136-148.
112. Siefert, J.L., 2009. Defining the mobilome. Methods in Molecular Biology 532: 13-27.
113. Siezen, R.J., Renckens, B., Van Swam, I., Peters, S., Van Kranenburg, R., Klerebeezem, M. and De Vos, W.M., 2005. Complete sequences of four plasmids of Lactococcus lactis subsp. cremoris SK11 reveal extensive adaptation to the dairy environment. Applied and Environmental Microbiology 71: 8371-8382.
114. Simon, R., Priefer, U. and Puhler, A., 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram-negative bacteria. Nature Biotechnology 1: 784-791.
115. Stanton, C., Gardiner, G., Meehan, H., Collins, K., Fitzgerald, G., Lynch, P.B. and Ross, R.P., 2001. Market potential for probiotics. The American Journal of Clinical Nutrition 73: 476S-783S.
116. Takata, T., Shirakawa, T., Kawasaki, Y., Kinoshita, S., Gotoh, A., Kano, Y. and Kawabata, M., 2006. Genetically engineered Bifidobacterium animalis expressing the Salmonella flagellin gene for the mucosal immunization in a mouse model. Journal of General Medicine 8: 1341-1346.
117. Tanaka, K., Samura, K. and Kano, Y., 2005. Structural and functional analysis of pTB6 from Bifidobacterium longum. Bioscience, Biotechnology, and Biochemistry 69: 422-425.
118. Tang, W., He, Y., Zhou, S., Ma, Y. and Liu, G., 2009. A novel Bifidobacterium infantis-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer. Journal of Experimental and Clinical Cancer Research 28: 155.
119. Tauch, A., Kassing, F., Kalinowski, J. and Pühler, A., 1995. The Corynebacterium xerosis composite transposon Tn5432 consists of two identical insertion sequences, designated IS1249, flanking the erythromycin resistance gene ermCX. Plasmid 34: 119-131.
120. Thomas, C.M., 2004. Evolution and population genetics of bacterial plasmids. In: Funnel, B.E. and Phillips, G.J. (eds.) Plasmid biology. ASM Press, Washington, DC, USA, pp. 509-528.
121. Tuohy, K.M., Probert, H.M., Smejkal, C.W. and Gibson, G.R., 2003. Using probiotics and prebiotics to improve gut health. Drug Discovery Today 8: 692-700.
122. Turroni, F., Foroni, E., O'Connell Motherway, M., Bottacini, F., Giubellini, V., Zomer, A., Ferrarini, A., Delledonne, M., Zhang, Z., Van Sinderen, D. and Ventura, M., 2010. Characterization of the serpin-encoding gene of Bifidobacterium breve 210B. Applied and Environmental Microbiology 76: 3206-3219.
123. Turroni, F., Peano, C., Pass, D.A., Foroni, E., Severgnini, M., Claesson, M.J., Kerr, C., Hourihane, J., Murray, D., Fuligni, F., Gueimonde, M., Margolles, A., De Bellis, G., O'Toole, P.W., Van Sinderen, D., Marchesi, J.R. and Ventura, M., 2012. Diversity of bifidobacteria within the infant gut microbiota. PLoS ONE 7: e36957.
124. Turroni, F., Van Sinderen, D. and Ventura, M., 2009. Bifidobacteria: from ecology to genomics. Frontiers in Bioscience 14: 4673-4684.
125. Van Hoek, A.H.A.M., Mayrhofer, S., Domig, K.J. and Aarts, H.J.M., 2008. Resistance determinant erm(X) is borne by transposon Tn5432 in Bifidobacterium thermophilum and Bifidobacterium animalis subsp. lactis. International Journal of Antimicrobial Agents 31: 544-548.
126. Ventura, M., Canchaya, C., Tauch, A., Chandra, G., Fitzgerald, G.F., Chater, K.F. and Van Sinderen, D., 2007. Genomics of Actinobacteria: tracing the evolutionary history of an ancient phylum. Microbiology and Molecular Biology Reviews 71: 495-548.
127. Ventura, M., Lee, J.H., Canchaya, C., Zink, R., Leahy, S., Moreno- Muñoz, J.A., O'Connell-Motherway, M., Higgins, D., Fitzgerald, G.F., O'Sullivan, D.J. and Van Sinderen, D., 2005. Prophage-like elements in bifidobacteria: insights from genomics, transcription, integration, distribution, and phylogenetic analysis. Applied and Environmental Microbiology 71: 8692-8705.
128. Ventura, M., O'Flaherty, S., Claesson, M.J., Turroni, F., Klaenhammer, T.R., Van Sinderen, D. and O'Toole, P.W., 2009a. Genome-scale analyses of health-promoting bacteria: probiogenomics. Nature Reviews in Microbiology 7: 61-71.
129. Ventura, M., Turroni, F., Lima-Mendez, G., Foroni, E., Zomer, A., Duranti, S., Giubellini, V., Bottacini, F., Horvath, P., Barrangou, R., Sela, D.A., Mills, D.A. and Van Sinderen, D., 2009c. Comparative analyses of prophage-like elements present in bifidobacterial genomes. Applied and Environmental Microbiology 75: 6929-6936.
130. Ventura, M., Turroni, F., Zomer, A., Foroni, E., Giubellini, V., Bottacini, F., Canchaya, C., Claesson, M.J., He, F., Mantzourani, M., Mulas, L., Ferrarini, A., Gao, B., Delledonne, M., Henrissat, B., Coutinho, P., Oggioni, M., Gupta, R.S., Zhang, Z., Beighton, D., Fitzgerald, G.F., O'Toole, P.W. and Van Sinderen, D., 2009b. The Bifidobacterium dentium Bd1 genome sequence reflects its genetic adaptation to the human oral cavity. PLoS Genetics 5: e1000785.
131. Ventura, M., Van Sinderen, D., Fitzgerald, G.F. and Zink, R., 2004. Insights into the taxonomy, genetics and physiology of bifidobacteria. Antonie van Leeuwenhoek 86: 205-223.
132. Watson, D., Sleator, R.D., Hill, C. and Gahan, C.G., 2008. Enhancing bile tolerance improves survival and persistence of Bifidobacterium and Lactococcus in the murine gastrointestinal tract. BMC Microbiology 8: 176.
133. Xu, Y.F., Zhu, L.P., Hu, B., Fu, G.F., Zhang, H.Y., Wang, J.J. and Xu, G.X., 2007. A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy. Cancer Gene Therapy 14: 151-157.
134. Yamamoto, S., Wada, J., Katayama, T., Jikimoto, T., Nakamura, M., Kinoshita, S., Lee, K.M., Kawabata, M. and Shirakawa, T., 2010. Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella Typhimurium in a murine typhoid fever model. Vaccine 28: 6684-6691.
135. Yasui, K., Kano, Y., Tanaka, K., Watanabe, K., Shimizu-Kadota, M., Yoshikawa, H. and Suzuki, T., 2009. Improvement of bacterial transformation efficiency using plasmid artificial modification. Nucleic Acids Research 37: e3.
136. Yazawa, K., Fujimori, M., Amano, J., Kano, Y. and Taniguchi, S., 2000. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Therapy 7: 269-274.
137. Yazawa, K., Fujimori, M., Nakamura, T., Sasaki, T., Amano, J., Kano, Y. and Taniguchi, S., 2001. Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors. Breast Cancer Research and Treatment 66: 165-170.
138. Yi, C., Huang, Y., Guo, Z.Y. and Wang, S.R., 2005. Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma. Acta Pharmacologica Sinica 26: 629-634.
139. Yildirim, Z., Winters, D.K. and Johnson, M.G., 1999. Purification, amino acid sequence and mode of action of bifidocin B produced by Bifidobacterium bifidum NCFB 1454. Journal of Applied Microbiology 86: 45-54.
140. Youseff, M., Müller-Beuthow, W. and Haenel, H., 1966. Isolierung von Bakteriophagen für anaerobe Laktobazillen aus dem Stuhl des Menschen. Naturwissenchaften 53: 589-590.
141. Yu, Z., Huang, Z., Sao, C., Huang, Y., Zhang, F., Yang, J., Lian, J., Zeng, Z., Luo, W., Zeng, W. and Deng, Q., 2012. Bifidobacterium as an oral delivery carrier of interleukin-12 for the treatment of Coxsackie virus B3-induced myocarditis in the Balb/c mice. International Immunopharmacology 12: 125-130.
142. Yu, Z., Huang, Z., Shao, C., Huang, Y., Zhang, F., Yang, J., Deng, L., Zeng, Z., Deng, Q. and Zeng, W., 2011. Oral administration of interferon-a2b-transformed Bifidobacterium longum protects BALB/c mice against coxsackievirus B3-induced myocarditis. Virology Journal 8: 525.
143. Yu, Z., Zeng, Z., Huang, Z., Lian, J., Yang, J., Deng, Q. and Zeng, W., 2010. Increased mRNA expression of interferon-induced Mx1 and immunomodulation following oral administration of IFNalpha2b- transformed Bifidobacterium longum to mice. Archives of Microbiology 192: 633-638.
144. Zhang, Z.Q., Yao, L.H. and Hou, Y.D., 1990. Construction and application of a high level expression vector containing PRPL promotor. Chinese Journal of Virology 6: 111-116.
145. Zhu, L.P., Yin, Y., Xing, J., Li, C., Kou, L., Hu, B., Wu, Z.W., Wang, J.J. and Xu, G.X., 2009. Therapeutic efficacy of Bifidobacterium longum-mediated human granulocyte colony-stimulating factor and/or endostatin combined with cyclophosphamide in mousetransplanted tumors. Cancer Science 100: 1986-1990.